Alebund

Committed to bringing innovative treatment solutions to patients with kidney disease worldwide

Shanghai, China · Founded 2018 · $271.0M raised

Headquarters
Shanghai
Employees
51–200
Founded
2018
Business Model
Other
Total Funding
$271.0M
Last Round
$81.5M Private EquityJun 2026
Rounds
4

About

Alebund Pharmaceuticals is a Shanghai-based clinical-stage biopharmaceutical company founded in 2018 by Gavin Xia and Jin Tian, developing novel therapies for renal diseases including chronic kidney disease, IgA nephropathy, FSGS, and ADPKD. Its pipeline includes 8 product candidates, 2 of which are in commercialization or have completed Phase 3 trials. The company listed on the Hong Kong Stock Exchange (09637.HK) in 2026 and operates manufacturing sites in Yangzhou and Shanghai.

Summary

Alebund is a Biotech company based in Shanghai, China, founded in 2018. It has raised $271.0M in total across 4 rounds, most recently a $81.5M Private Equity round in Jun 2026. Investors include 3H Health, Loyal Valley Capital and Morningside Group.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJun 2026
$81.5M

Sign up to see all 4 events

Funding: Series B through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alebund on Indexed.vc
<a href="https://indexed.vc/companies/alebund"><img src="https://indexed.vc/api/badge/company/alebund" alt="Alebund on Indexed.vc" width="260" height="76" /></a>